Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Axsome Thera (AXSM)

$55.79 0.00 (0.00%)

19:24 EDT AXSM Stock Quote Delayed 20 Minutes

Volume:

Previous Close $55.79

Market Cap 1.43B

PE Ratio -53.13

EPS -1.05

Volume (Avg. Vol.)

Day's Range 55.79 - 55.79

52-Week Range 13.11 - 109.94

Dividend & Yield N/A (N/A)

AXSM Stock Predictions, Articles, and Axsome Thera News

From the Web

Axsome's (AXSM) AXS-05 Fails to Meet Main Goal in TRD Study

From Zacks Investment Research Mar 31, 2020

Axsome's (AXSM) AXS-05 meets key secondary endpoints in late-stage study for addressing patients with treatment resistant depression. However, the primary endpoint did not reach statistical significance.

80 Biggest Movers From Yesterday

From Benzinga Mar 31, 2020

Gainers Top Ships Inc. (NASDAQ: TOPS) shares surged 130.2% to close at $0.5399 on Monday after jumping 193% on Friday. SuperCom Ltd. (NASDAQ: SPCB) shares jumped 120.4% to close...

Best & Worst Performing Mid Cap Stocks for March 30, 2020

From StockNews.com Mar 30, 2020

SRCL – SRCL leads the way today as the best performing mid cap stock, closing up 15.62%.

Axsome Therapeutics' Key Drug Candidate Whiffs in Phase 3 Trial

From The Motley Fool Mar 30, 2020

The company's depression drug AXS-05 failed to meet its primary endpoints in the study, although it did hit the secondary endpoints.

55 Stocks Moving In Monday's Mid-Day Session

From Benzinga Mar 30, 2020

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares climbed 202% to $1.48 after the company announced it has shipped Coronavirus quarantine compliance technology for an immediate pilot....

Here's Why Axsome Therapeutics Fell as Much as 14.7% Today

From The Motley Fool Mar 30, 2020

An important clinical trial delivered mixed results.

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy